Is cefuroxime (a cephalosporin antibiotic) safe to use in a lactating (breastfeeding) woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime Safety During Breastfeeding

Cefuroxime is compatible with breastfeeding and can be safely used in lactating women. 1

Guideline-Based Safety Classification

  • The European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) explicitly classifies cefuroxime as "compatible" with breastfeeding, representing the highest safety designation for antibiotics during lactation 1
  • This classification is supported by human data indicating that cefuroxime and other cephalosporins are not teratogenic at usual therapeutic doses 1
  • Multiple international guidelines consistently recommend cephalosporins, including cefuroxime, as first-line safe options for breastfeeding mothers 2, 3, 4

FDA Drug Label Information

  • The FDA drug label states that cefuroxime is excreted in human milk, and caution should be exercised when administered to nursing women 5
  • However, this standard cautionary language does not contraindicate use, and clinical guidelines provide more specific safety assurance 1

Clinical Evidence Supporting Safety

  • A prospective study of 38 breastfeeding women treated with cefuroxime found only 1 infant (2.6%) experienced adverse effects, which was not significantly different from controls (9%) 6
  • All adverse effects observed were minor, self-limiting, and did not necessitate interruption of breastfeeding 6
  • Cefuroxime concentrations measured in breast milk ranged from 0.09 to 0.59 μg/ml in healthy milk and 0.57 to 1.05 μg/ml in purulent milk, representing low levels of drug transfer 7
  • Cephalosporins have limited oral bioavailability in infants, meaning even the small amounts present in breast milk are poorly absorbed by the nursing infant 2

Important Monitoring Considerations

  • Monitor all breastfed infants for gastrointestinal effects (mild diarrhea, altered intestinal flora) when mothers receive any systemic antibiotic, though serious adverse events are rare 1, 2
  • Be aware that antibiotics in breast milk could potentially cause falsely negative cultures if a febrile infant requires microbiological evaluation 1, 2
  • These monitoring considerations apply to all antibiotics during lactation, not specifically to cefuroxime 1

Clinical Decision Algorithm

First-line choice: Cefuroxime and other cephalosporins (cephalexin, ceftriaxone) are explicitly compatible with breastfeeding and should be used preferentially 1, 2, 4

Equivalent alternatives: Penicillins such as amoxicillin are also classified as compatible and represent equally safe first-line options 1, 2, 3

When to avoid: There are no specific contraindications to cefuroxime use during breastfeeding in healthy term infants 1, 6

Common Pitfalls to Avoid

  • Do not unnecessarily discontinue breastfeeding when cefuroxime is prescribed—the benefits of continued breastfeeding far outweigh the minimal theoretical risks of antibiotic exposure through breast milk 2
  • Do not confuse pregnancy safety with lactation safety—while some antibiotics have different risk profiles in pregnancy versus lactation, cefuroxime is safe in both contexts 1
  • Do not delay necessary antibiotic treatment due to unfounded concerns about breastfeeding safety when using compatible agents like cefuroxime 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Use During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotics to Avoid During Pregnancy and Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of Antibiotics During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Clinical studies on cefuroxime axetil in acute mastitis].

The Japanese journal of antibiotics, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.